LCM
INSM icon

Lattice Capital Management’s Insmed INSM Stock Holding History

Lattice Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,700
Closed -$255K – 25
2024
Q4 		$255K Buy
+3,700
New +$266K 0.21% 27

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Lattice Capital Management's INSM Position: Q1 2025 in Review

Lattice Capital Management sold out of Insmed (INSM) in Q1 2025, closing a stake of 3,700 shares — an estimated $255K sold.

Lattice Capital Management first reported a position in INSM in Q4 2024 and held it in 1 quarter. The position peaked at $255K in Q4 2024. 441 funds tracked by Wall St. Rank hold INSM as of Q1 2025.

  • Lattice Capital Management reported no remaining Insmed position as of Q1 2025 after selling out during the quarter.
  • Lattice Capital Management sold 3,700 Insmed shares in Q1 2025, an estimated $255K.
  • Lattice Capital Management first reported a position in Insmed in Q4 2024 and held it in 1 quarter.
  • Lattice Capital Management's Insmed position peaked at $255K in Q4 2024.
  • 441 funds tracked by Wall St. Rank held Insmed as of Q1 2025.

Based on Lattice Capital Management's 13F filing for Q1 2025, filed 30 Apr 2025.